An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
about
On the binding modes of metal NHC complexes with DNA secondary structures: implications for therapy and imaging.Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand.Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity.Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.Serum-binding properties of isosteric ruthenium and osmium anticancer agents elucidated by SEC-ICP-MS
P2860
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
@en
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
@nl
type
label
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
@en
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
@nl
prefLabel
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
@en
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
@nl
P2093
P2860
P50
P356
P1476
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin
@en
P2093
Annesha Chatterjee
Arindam Bhattacharyya
Beatrix Alte
Gerhard Wiche
Johanna C Mader
Klaudia Cseh
Michaela Hejl
Samir Jana
Tamara Weiss
P2860
P304
P356
10.1002/ANIE.201702242
P407
P50
P577
2017-05-26T00:00:00Z